Recent clinical data confirmed that the cytoplasmic PARP-1 expression in the needle core biopsies of breast cancer was low, and low PARP-1 expression was associated with no or poor response to chemotherapy [17]. The gene discussed is PARP1; the disease is breast carcinoma.